Rye Brook Capital LLC: NVDA position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Rye Brook Capital LLC on NVDA, newest first. How the timeline and the estimate are built.
Rye Brook Capital LLC held 1,400 NVDA shares at 2026-09-30 per its 13F-HR filed 2026-10-07.
the latest 13F is the newest step
- period ended2026-09-3013F 1,400 sharesChange vs previous 13F +400 shares
0.21% of the 13F portfolio, value $320,000.
13F-HR 0001844147-26-000004 filed by Rye Brook Capital LLC
Accepted , ingested - period ended2026-06-3013F 1,000 sharesChange vs previous 13F +1,000 shares
0.14% of the 13F portfolio, value $200,000.
13F-HR 0001844147-26-000003 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 0 sharesChange vs previous 13F -1,000 shares
13F-HR 0001844147-26-000002 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-12-3113F 1,000 sharesChange vs previous 13F 0 shares
0.17% of the 13F portfolio, value $187,000.
13F-HR 0001844147-26-000001 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 1,000 sharesChange vs previous 13F 0 shares
0.16% of the 13F portfolio, value $187,000.
13F-HR 0001844147-25-000005 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 1,000 sharesChange vs previous 13F not available
0.16% of the 13F portfolio, value $158,000.
13F-HR 0001844147-25-000003 filed by Rye Brook Capital LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).